CEVR’s fall newsletter is out!

Behind the scenes with Peter Neumann: 16 Years as CEVR Director

How might US health plans cover efgartigimod for generalized myasthenia gravis? Lessons from the SPEC Database

Call for papers: 2021 Tufts-CEVR's cost-effectiveness analysis paper of the year award